Dicerna Pharmaceuticals reported $2.87B in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Agenus AGEN:US $ 1.22B 664.46M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amgen AMGN:US $ 140.05B 3.22B
Arrowhead Research ARWR:US $ 8.62B 1.74B
Biogen BIIB:US $ 52.13B 9.52B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Dicerna Pharmaceuticals DRNA:US $ 2.87B 918.39M
Exelixis EXEL:US $ 5.71B 1.36B
Gilead Sciences GILD:US $ 86.36B 4.99B
GlaxoSmithKline GSK:LN 71.42B 6.62B
Immunogen IMGN:US $ 1.32B 300.21M
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
Intrexon XON:US $ 1.35B 76.37M
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Lexicon Pharmaceuticals LXRX:US $ 662.74M 184.62M
Macrogenics MGNX:US $ 1.62B 176.65M
Merk MRK:US $ 196918.18M 1780.24M
Mirati Therapeutics MRTX:US $ 8.31B 483.81M
Pfizer PFE:US $ 219205.69M 17108.81M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Regulus Therapeutics RGLS:US $ 60.92M 52.19M
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B